Learn more

METACRINE INC

Overview
  • Total Patents
    64
  • GoodIP Patent Rank
    22,888
  • Filing trend
    ⇧ 2300.0%
About

METACRINE INC has a total of 64 patent applications. It increased the IP activity by 2300.0%. Its first patent ever was published in 2016. It filed its patents most often in WIPO (World Intellectual Property Organization), United States and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are ARBUTUS BIOPHARMA INC, CHENGDU GUOHONG PHARMACEUTICAL CO LTD and ENTERPRISE THERAPEUTICS LTD.

Patent filings per year

Chart showing METACRINE INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Smith Nicholas D 50
#2 Govek Steven P 44
#3 Nagasawa Johnny Y 36
#4 Douglas Karensa L 17
#5 Lai Andiliy G 15
#6 Smith Nicholas 6
#7 Steven P Govek 4
#8 Johnny Y Nagasawa 4
#9 Nicholas D Smith 4
#10 Chen Mi 3

Latest patents

Publication Filing date Title
WO2020086747A2 Ssao inhibitors and uses thereof
WO2020061117A1 Farnesoid x receptor agonists and uses thereof
WO2020061118A1 Farnesoid x receptor agonists and uses thereof
CA3112414A1 Farnesoid x receptor agonists for the treatment of disease
WO2020061115A1 Crystalline forms of a farnesoid x receptor agonist
WO2020061116A1 Farnesoid x receptor agonists and uses thereof
CA3112411A1 Farnesoid x receptor agonists and uses thereof
WO2020061112A1 Farnesoid x receptor agonists and uses thereof
WO2019241751A1 Ssao inhibitors and uses thereof
US2020131142A1 Farnesoid x receptor agonists and uses thereof
EP3596053A1 Farnesoid x receptor agonists and uses thereof
WO2018170173A1 Farnesoid x receptor agonists and uses thereof
US2020131132A1 Farnesoid x receptor agonists and uses thereof
CA3056019A1 Farnesoid x receptor agonists and uses thereof
WO2018018010A1 Fgf mutants and uses thereof
WO2017049177A1 Farnesoid x receptor agonists and uses thereof
WO2017049173A1 Farnesoid x receptor agonists and uses thereof
EP3350164A1 Farnesoid x receptor agonists and uses thereof
US2018244606A1 Farnesoid X receptor agonists and uses thereof